|
Bupropion for the Treatment of Methamphetamine Dependence - 1 Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for certified health advice, travels to or treatment by using a genuine physician. We are not physicians. Always consult your dr. on Bupropion for the Treatment of Methamphetamine Dependence - 1 conditions. Clinical Trials Search.org is a site committed to listing clinical research studies in human subjects. Bupropion for the Treatment of Methamphetamine Dependence - 1 Clinical research trials and Bupropion for the Treatment of Methamphetamine Dependence - 1 health trials occur in hundreds of cities throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically assess the effectivity of new drugs. The propose of the studies / undertakings is to resolve certain human health questions. Clinical trials are a popular means for physicians, government agencies, and private sector companies to locate treatments for all sorts of conditions, including Bupropion for the Treatment of Methamphetamine Dependence - 1. Bupropion for the Treatment of Methamphetamine Dependence - 1 Clinical Trials and other clinical trials permit volunteers to acquire medical treatment choices before they are available to the masses. Some times the test subjects obtain professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a Bupropion for the Treatment of Methamphetamine Dependence - 1 clinical trial. Participants oftentimes recieve the most expert healthcare available for their Bupropion for the Treatment of Methamphetamine Dependence - 1 condition. Hazards are a reality, however, and can include extra or frequent physician visits, health risks (potentially life-endangering), and/or the treatment being uneffective. Trials are federally governed with rigorous guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "B" Clinical Trials Conditions > Bupropion for the Treatment of Methamphetamine Dependence - 1  Bupropion for the Treatment of Methamphetamine Dependence - 1
Bupropion for the Treatment of Methamphetamine Dependence - 1
For Condition: methamphetamine
Status: Recruiting
Sponsor(s): National Institute on Drug Abuse (NIDA) ,
Synopsis: A phase-2, double-blind, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence
Details: A double-blind, placebo-controlled, parallel-group design study in which 100 subjects will be randomly assigned to placebo or bupropion for 12 weeks with follow-up assessments 4 weeks following treatment. Adaptive randomization will be used to balance treatment groups based on gender.
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/65 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - Subject must have methamphetamine dependence as determined by the DSM-IV diagnosis - Subject must be willing to comply with study procedures. - Subject must be able to verbalize understanding of consent form, able to provide written consent, and verbalize willingness to complete study procedures - Subject must be seeking treatment for methamphetamine dependence Exclusion Criteria: Please contact site for more information.
Total Enrollment: 100
Location and Contact Information:
Overall Study Official:
RichardRawson, Principal Investigator, University of California, Los Angeles
South Bay Treatment Center *Recruiting*
San Diego, California, 92105
United States
Recruiting Joseph Mawhinney 858-581-5776
University of Missouri - Kansas City *No longer recruiting*
Kansas City, Missouri, 64108
United States
No longer recruiting
Pacific Addiction Research Center *No longer recruiting*
Honolulu, Hawaii, 96813
United States
No longer recruiting
Matrix Institute on Addictions *No longer recruiting*
Costa Mesa, California, 92627
United States
No longer recruiting
Powell Chemical Dependency Center *No longer recruiting*
Des Moines, Iowa,
United States
No longer recruiting
Additional Information:
Study ID Numbers: NIDA-CTO-0008-1;
Study Start Date: July 2003
Record last reviewed: May 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00069251
Other Methamphetamine Studies:
1. Bupropion for the Treatment of Methamphetamine Dependence - 1
Related Studies:
Other methamphetamine Clinical Trials
Other California Clinical Trials
Other San Diego Clinical Trials
Bupropion for the Treatment of Methamphetamine Dependence - 1
|
|
|
|
|
|
|
|
